Amyotrophic Lateral Sclerosis Market Will Generate Booming Growth Opportunities to 2033Posted by Ganesh Shinde on March 2nd, 2023  According to a recent FMI study, the global Amyotrophic Lateral Sclerosis Market is expected to reach US$ 743.90 Million in 2023 and US$ 1332.22 Million by 2023 to 2033, at a CAGR of 6%. The market for Amyotrophic Lateral Sclerosis registered a CAGR of 4% in the historical period 2017 to 2022. The growth of the Amyotrophic Lateral Sclerosis market can be attributed to the rising geriatric population, growing awareness about ALS, and increasing incidence rate. In addition to this, various measures adopted by the government or healthcare organizations to spread awareness are further pushing the market growth. In June 2022, the United States Food and Drug Administration (FDA) launched an action plan for Rare Neurodegenerative Diseases including Amyotrophic Lateral Sclerosis (ALS). This action plan is the five-year strategy being implemented by the United States FDA with the motive to improve and extend the lives of people living with rare neurodegenerative diseases. With the implementation of the plan, advancements are taking place in the development of effective medical products to offer novel treatments to all patients. In terms of market share and revenue, the North American market is predicted to be the most lucrative market during the forecast period with a revenue share of 20%. The region's growth is driven by the presence of various key players who are working on research and development of effective solutions. For instance, in May 2022, Mitsubishi Tanabe Pharma America received the United States Food and Drug Administration Approval for RADICAVA ORS (edaravone) for the Treatment of amyotrophic lateral sclerosis. Market Competition Key players in the Amyotrophic Lateral Sclerosis market are Mitsubishi Tanabe Pharma Corporation; Otsuka Pharmaceutical Co., Ltd.; BrainStorm Therapeutics; Biogen Inc.; Corestem; AB Science; F.Hoffmann-La Roche AG; Biohaven Pharmaceutical; Sun Pharmaceutical; and Ionis Pharmaceuticals, Inc. Get More Insights@ https://www.futuremarketinsights.com/reports/amyotrophic-lateral-sclerosis-market Key Segments Profiled in the Amyotrophic Lateral Sclerosis Industry Survey Treatment:
Distribution Channel:
Like it? Share it! More by this author |